Xtant Medical Holdings, Inc. develops, manufactures, and markets biologics products in the United States and internationally. The company offers products for use in various applications, including enhancing fusion in spine surgery, relief of back pain with a facet joint stabilization, promotion of bone growth in foot and ankle surgery, promotion of skull healing, neurosurgery, and regeneration in knee and other joint surgeries. Its products include OsteoSponge, which provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC, a subchondral bone void filler; OsteoSelect DBM putty, an osteoinductive product used by surgeons as a bone void filler in the extremities and pelvis; and OsteoWrap that wraps around non-union fractures to assist with fusion, and could be used in conjunction with a hardware plate system. The company also provides OsteoLock and BacFast HD facet stabilization dowels used to augment spinal procedures; OsteoSTX for posterolateral spine surgery applications, including scoliosis procedures; and hMatrix dermal scaffold, which promotes cellular ingrowth, tissue vascularization, and regeneration. In addition, it processes and sells sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. Further, the company's products include 3Demin cortical fibers, 3Demin boats, and 3Demin strips made from cortical bone and primarily used in spine procedures. It markets its products through direct sales force, as well as through distributor relationships. The company was formerly known as Bacterin International Holdings, Inc. and changed its name to Xtant Medical Holdings, Inc. in July 2015. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.